Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.0413 | 0.0403 |
Mycobacterium leprae | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN | 0.0022 | 0.001 | 0.5 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0465 | 0.1197 | 0.1553 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0465 | 0.1197 | 0.1553 |
Plasmodium vivax | LCCL domain-containing protein | 0.0022 | 0.001 | 0.5 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.288 | 0.7653 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0176 | 0.0424 | 0.0014 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0253 | 0.0628 | 0.0295 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.288 | 0.7653 | 0.7651 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.288 | 0.7653 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0413 | 0.1058 | 0.8827 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0022 | 0.001 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0465 | 0.1197 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.0383 | 0.0373 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.0367 | 0.0357 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0022 | 0.001 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.288 | 0.7653 | 1 |
Loa Loa (eye worm) | TK/DDR protein kinase | 0.0155 | 0.0367 | 0.0357 |
Toxoplasma gondii | hypothetical protein | 0.3757 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.288 | 0.7653 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3757 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.288 | 0.7653 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.0173 | 0.0414 | 0.0528 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0022 | 0.001 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.288 | 0.7653 | 0.5 |
Onchocerca volvulus | 0.0022 | 0.001 | 0.0241 | |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.288 | 0.7653 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.288 | 0.7653 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.288 | 0.7653 | 0.5 |
Brugia malayi | Stress-activated protein kinase jnk-1 | 0.0465 | 0.1197 | 0.1082 |
Mycobacterium tuberculosis | Possible arabinofuranosyltransferase AftD | 0.0022 | 0.001 | 0.5 |
Entamoeba histolytica | SH2-protein kinase domain containing protein | 0.0018 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Brugia malayi | P38 map kinase family protein 2 | 0.288 | 0.7653 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase ABL1 | 0.0419 | 0.1074 | 0.1392 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.288 | 0.7653 | 0.5 |
Trichomonas vaginalis | hypothetical protein | 0.0022 | 0.001 | 0.5 |
Onchocerca volvulus | 0.0176 | 0.0424 | 1 | |
Echinococcus granulosus | tyrosine protein kinase ABL1 | 0.0419 | 0.1074 | 0.1392 |
Plasmodium vivax | LCCL domain-containing protein | 0.0022 | 0.001 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0022 | 0.001 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0465 | 0.1197 | 0.1188 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.0419 | 0.1074 | 0.1065 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0028 | 0.0028 | 0.0023 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3757 | 1 | 1 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.3757 | 1 | 1 |
Trichomonas vaginalis | beta-hexosaminidase B, putative | 0.0022 | 0.001 | 0.5 |
Echinococcus granulosus | discoidin domain receptor | 0.0172 | 0.0413 | 0.0526 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0.001 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.